General Information of Drug (ID: DMGJYWF)

Drug Name
6-Benzylamino-5-bromo-1H-pyrimidine-2,4-dione
Synonyms
CHEMBL161517; 28484-80-2; 5-bromo-6-(benzylamino)uracil; NSC212354; AC1L7G2Y; 6-Benzylamino-5-bromo-1H-pyrimidine-2,4-dione; 6-(benzylamino)-5-bromo-1H-pyrimidine-2,4-dione; DTXSID60309581; BDBM50022146
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 296.12
Logarithm of the Partition Coefficient (xlogp) 1.6
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C11H10BrN3O2
IUPAC Name
6-(benzylamino)-5-bromo-1H-pyrimidine-2,4-dione
Canonical SMILES
C1=CC=C(C=C1)CNC2=C(C(=O)NC(=O)N2)Br
InChI
InChI=1S/C11H10BrN3O2/c12-8-9(14-11(17)15-10(8)16)13-6-7-4-2-1-3-5-7/h1-5H,6H2,(H3,13,14,15,16,17)
InChIKey
SLPLXDQXLWOWDS-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
309896
CAS Number
28484-80-2
TTD ID
D0D0DV

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
DNA topoisomerase (TOP) TT2GPK3 NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Inhibitors of Bacillus subtilis DNA polymerase III. Influence of modifications in the pyrimidine ring of anilino- and (benzylamino)pyrimidines. J Med Chem. 1986 May;29(5):676-81.